Top Stories

Apple Inc. (AAPL) reported its third straight quarter of iPhone sales and revenue declines after the market closed on Tuesday. The tech giant's fourth-quarter profit trumped Wall Street expectations, while revenues fell short. Although, Apple reported...

Consumer prices in Australia were up 1.3 percent on year in the third quarter of 2016, the Australian Bureau of Statistics said on Wednesday. That exceeded forecasts for 1.1 percent following the 1.0 percent increase in the previous three months. On...


With Donald Trump refusing to commit to accepting the results of the upcoming presidential election, a new Politico/Morning Consult poll found that nearly a quarter of the Republican nominee's supporters think he should challenge the results if Democratic...

The Indonesia stock market on Tuesday ended the modest two-day winning streak in which it had gathered almost 20 points or 0.4 percent. The Jakarta Composite Index now rests just beneath the 5,400-point plateau, and the market may extend its losses on...


Bill Murray had a fantastic weekend. The comedic actor was awarded the Mark Twain Prize for American Humor and his favorite team; the Chicago Cubs won the National League division. There was concern that Murray wouldn't even show up to accept the...

Asian-Markets2_18Oct16.jpg Asian stock markets are mostly higher with modest gains on Wednesday following the positive cues overnight from Wall Street and as data showed that China's economic growth was in line with expectations. Crude oil prices further edged higher in Asian trades.
Walmart-Vudu-101816.jpg Walmart's subscription-free, premium video streaming service Vudu Tuesday launched Vudu Movies on Us, offering thousands of HD movies and TV shows with limited commercials for free.
Asian-Market-100912_19Oct16.jpg European stocks are seen opening higher on Wednesday after key data out of China came along expected lines. The world's second-biggest economy expanded at an annual rate of 6.7 percent in the third quarter of 2016, in line with estimates. Retail sales...
chinagdp-101916.jpg China's economy grew at a steady pace in the third quarter as domestic factors helped to maintain the momentum, despite subdued global demand. Gross domestic product expanded 6.7 percent year-on-year in the three months to September, the same pace of growth as seen in the first and second quarters, the National Bureau of Statistics said Wednesday. The annual growth was in line with economists' ex
DonaldTrump-Campaign1-102116.jpg Less than three weeks before Election Day, the results of a new Atlanta Journal-Constitution poll show Donald Trump and Hillary Clinton are virtually tied in Georgia. The poll showed Trump with a slim 44 percent to 42 percent lead over Clinton among likely Georgia voters, with the two-point gap well within the margin of error.
Images1-102116.jpg Former Ku Klux Klan leader David Duke has just enough support to qualify for a televised debate in Louisiana's Senate race. A survey by Raycom Media found that Duke met the 5 percent threshold needed to participate in the debate, which will be held at Dillard University, a historically black university in New Orleans.
Euro-PMI-102416.jpgEurozone private sector expanded at the fastest pace thus far this year, led by a strong rebound in Germany, while the pace of growth eased in France. The Composite Output Index, which combines manufacturing and services, rose to 53.7 from 52.6 in September, preliminary results of the purchasing managers' survey by IHS Markit showed Monday.
A new study shows that caffeine does not seem to have adverse effects on individuals with irregular heartbeats. The results of the study were published online October 17 in the journal JAMA Internal Medicine. The study included 51 people with heart failure. The study was conducted by separating the people into two groups.
The Australian stock market is notably lower on Wednesday following the negative lead from Wall Street and lower crude oil prices. Investors also digested local inflation data. In late-morning trades, the benchmark S&P/ASX 200 Index is losing 74.90 points or 1.38 percent to 5,367.90, slightly off...
The biotech space is not for the faint hearted, given the ebbs and flows in terms of the returns from investing in it. However, for one who perseveres and astutely devises strategies with full cognizance of key regulatory events coming up, the probability of drug candidates getting FDA's blessings and sympathy plays in the space, it provides a sea of opportunity and huge upside prospects. More
Dipexium Pharmaceuticals Inc. (DPRX) said Tuesday that the OneStep-1 and OneStep-2 Phase 3 clinical trials of Locilex (pexiganan cream 0.8%) in patients with mild infections of diabetic foot ulcers or Mild DFI did not meet the primary clinical endpoint... More
PS4-Pro-102416.jpg As Sony Corp. prepares to launch the new PlayStation 4 Pro gaming console on November 10, several new games that are compatible with the console have also been confirmed for launch. Game developers are readying to provide PlayStation 4 Pro support for many games on PS4.
Follow RTT
Economic Calendar
10/25/16 20:30CPI (Q-o-Q)Q3 Australia
10/25/16 20:30CPI (Y-o-Y)Q3 Australia
10/25/16 20:30Trimmed Mean (Q-o-Q)Q3 Australia
10/25/16 20:30Trimmed Mean (Y-o-Y)Q3 Australia
10/25/16 20:30Weighted Median (Q-o-Q)Q3 Australia
10/25/16 20:30Weighted Median (Y-o-Y)Q3 Australia
Complete Economic Calendar
FDA Calendar
Event DateSymbolDrug NameEvent Name
01/07/17ANACCrisaborole topical ointment, 2% (NDA)FDA decision on Crisaborole for treatment of mild-to-moderate atopic dermatitis in children and adults.
01/03/17VCELMACI (BLA)FDA decision on MACI for the treatment of symptomatic cartilage defects of the knee in adult patients
12/28/16RHHBYOCREVUS (BLA)FDA decision on OCREVUS for the treatment of relapsing multiple sclerosis and primary progressive multiple sclerosis
12/28/16AAAPLutathera (NDA)FDA decision on Lutathera for the treatment of gastro entero pancreatic neuroendocrine tumors
12/28/16CEMPSolithera IV (NDA)FDA decision on Solithera as a treatment for community-acquired bacterial pneumonia
Complete FDA Calendar